thesesdissertations_119_OBJ.pdf (1.91 MB)
FAT-RELATED PATHWAYS MAY REPRESENT THERAPEUTIC TARGETS FOR MULTIPLE MYELOMA TREATMENT
thesis
posted on 2023-08-04, 12:48 authored by Peter J. RoehrichMultiple myeloma is a blood cancer for which few therapies exist, most of which are limited by toxicity and tumor resistance. Fatty acid synthase, an enzyme which catalyzes the conversion of carbohydrate to fatty acids, is highly expressed in multiple myeloma, among other cancers. This research investigated the potential of orlistat, a fatty acid synthase inhibitor, as a multiple myeloma therapeutic in vitro. In vitro, orlistat reduced proliferation of multiple myeloma cells, induced apoptosis, slowed progression through the cell cycle, and altered expression of survival and mitotic genes.
History
Publisher
American UniversityNotes
Degree awarded: M.S. Biology. American UniversityHandle
http://hdl.handle.net/1961/11103Usage metrics
Categories
No categories selectedLicence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC